It has been known for some time that multitransfused thalassaemic patients are at high risk of contracting hepatitis B virus infection.'-This risk has been reduced considerably by screening blood donors for hepatitis B virus surface antigen, using radioimmunoassay. Where there is a medium or high incidence of asymptomatic carriers, however, such as in Italy and other Mediterranean countries, where the percentage of post-transfusion hepatitis B infection (three per cent) is still such that it cannot be disregarded, most cases of post-transfusion hepatitis are attributable to non-A, non-B virus.45 Cytomegalovirus hepatitis does occur, but in a negligible percentage. Post-transfusion hepatitis together with iron accumulation play an important part in the onset and evolution of liver disease in thalassaemic patients; their exact role is still, however, unknown. 6 The aim of our study was to evaluate the prevalence and evolution of hepatitis B and non-B viruses by means of a serial study of hepatitis B virus markers in 128 multitransfused thalassaemic patients during a four year observation period. 12 , the number of patients with antibodies had increased, and the one subject who was hepatitis B surface antigen positive at the beginning was still positive.
The figure shows the serologic findings at the end of the study for all the patients subdivided according The probability of coming into contact with hepatitis B virus increases in direct proportion to the number of transfusions, and thus age: in fact all the thalassaemic children over the age of 12 years were positive for one or more hepatitis B markers. The fact that the older patients were all positive for hepatitis B markers could, however, be partly historical. In other words, it seems that our patients all come into contact with hepatitis B virus but the infectivity must be generally so low that it does not result in hepatitis, although it causes seroconversion.
Of particular interest are the episodes of acute hepatitis in 32 patients shown by the serial study of the transaminase activities.
For our patients the risk of contracting hepatitis B was clearly higher than that reported in other series of multitransfused subjects, even though it has reduced noticeably in past years.9 In the present study there were 23 episodes of hepatitis B attributable to non-A, non-B virus-about 75% of the episodes observed. This percentage is lower than that reported by other authors in series of multitransfused subjects in the USA, Italy, and Australia.5 9 10 We also showed the possibility of double infection since one patient presented two episodes of increased activities of transaminases, separated by an interval of nine months. The first increase was associated with negativity to all the hepatitis virus markers and was attributable to non-A, non-B hepatitis; the second, in which the specific IgM values were positive, was attributable to cytomegalovirus hepatitis.
The sustained increase in the transaminase activities may be partly explained by the histologic pictures of chronic aggressive hepatitis described previously by some of us.1I It is probable, however, that pictures of chronic hepatitis are produced by hepatitis B virus only exceptionally; most patients have a chronic hepatitis non-A, non-B, although it is not excluded that the iron overload is responsible for the persistence of chronic inflammatory disease even in cases with optimal hepatitis B virus clearance. [12] [13] In conclusion, early hepatitis B vaccination of thalassaemic children could prevent hepatitis B virus infection. Furthermore, more careful selection of blood donors, excluding from donation those impli- 
